Szczegóły publikacji

Opis bibliograficzny

Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis / Natalia Celejewska-Wójcik, Krzysztof Wójcik, Maria Ignacak-Popiel, Adam ĆMIEL, Katarzyna Tyrak, Anna Gielicz, Aleksander Kania, Paweł Nastałek, Marek Sanak, Lucyna Mastalerz // Allergy ; ISSN 0105-4538. — 2020 — vol. 75 iss. 4, s. 831–840. — Bibliogr. s. 839–840, Abstr. — Publikacja dostępna online od: 2019-12-05

Autorzy (10)

  • Celejewska-Wójcik Natalia
  • Wójcik Krzysztof t
  • Ignacak-Popiel Maria
  • AGHĆmiel Adam
  • Tyrak Katarzyna E.
  • Gielicz Anna
  • Kania Aleksander
  • Nastałek Paweł
  • Sanak Marek
  • Mastalerz Lucyna

Słowa kluczowe

NSAID-exacerbated respiratory diseaselatent class analysisinduced sputumeicosanoidsphenotype

Dane bibliometryczne

ID BaDAP128701
Data dodania do BaDAP2020-06-10
Tekst źródłowyURL
DOI10.1111/all.14141
Rok publikacji2020
Typ publikacjiartykuł w czasopiśmie
Otwarty dostęptak
Creative Commons
Czasopismo/seriaAllergy

Abstract

Background: Induced sputum (IS) allows to measure mediators of asthmatic inflammation in bronchial secretions. NSAID-exacerbated respiratory disease (NERD) is recognized as a distinct asthma phenotype, usually with a severe course, eosinophilic airway inflammation, and increased production of pro-inflammatory eicosanoids. A more insightful analysis of NERD patients has shown this phenotype to be nonhomogeneous. Objective: We aimed to identify possible subphenotypes in a cohort of NERD patients with the means of latent class analysis (LCA). Methods: A total of 95 asthma patients with aspirin hypersensitivity underwent sputum induction. High-performance liquid chromatography or gas chromatography coupled with mass spectrometry was used to profile eicosanoids in induced sputum supernatant (ISS). Sixteen variables covering clinical characteristics, IS inflammatory cells, and eicosanoids were considered in the LCA. Results: Three classes (subphenotypes) were distinguished within the NERD cohort. Class 1 subjects had mild-to-moderate asthma, an almost equal distribution of inflammatory cell patterns, the lowest concentrations of eicosanoids, and logLTE4/logPGE2 ratio. Class 2 represented severe asthma with impaired lung function despite high doses of steroids. High sputum eosinophilia was in line with higher pro-inflammatory LTE4 in ISS and the highest logLTE4/logPGE2 ratio. Class 3 subjects had mild-to-moderate asthma and were also characterized by eosinophilic airway inflammation, yet increased production of pro- (LTE4, PGD2 and 11-dehydro-TBX2) was balanced by anti-inflammatory PGE2. The value of logLTE4/logPGE2 was between values calculated for classes 1 and 3, similarly to disease control and severity. Conclusions: LCA revealed three distinct NERD subphenotypes. Our results support a more complex pathobiology of aspirin hypersensitivity. Considering NERD heterogeneity, the relationship between inflammatory pathways and clinical manifestations of asthma may lead to more individualized treatment in difficult to treat patients in the future. © 2019 The Authors. Allergy published by John Wiley & Sons Ltd

Publikacje, które mogą Cię zainteresować

artykuł
#128111Data dodania: 15.7.2020
Artificial neural network identifies nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD) cohort / Katarzyna Ewa Tyrak, Kinga Pajdzik, Ewa Konduracka, Adam ĆMIEL, Bogdan Jakieła, Natalia Celejewska-Wójcik, Gabriela Trąd, Adrianna Kot, Anna Urbańska, Ewa Zabiegło, Radosław Kacorzyk, Izabela Kupryś-Lipińska, Krzysztof Oleś, Piotr Kuna, Marek Sanak, Lucyna Mastalerz // Allergy ; ISSN 0105-4538. — 2020 — vol. 75 iss. 7, s. 1649-1658. — Bibliogr. s. 1657-1658, Abstr. — Publikacja dostępna online od: 2020-02-03
artykuł
#135657Data dodania: 24.9.2021
Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease / Katarzyna E. Tyrak, Kinga Pajdzik, Bogdan Jakieła, Izabela Kupryś-Lipińska, Adam ĆMIEL, Radosław Kacorzyk, Gabriela Trąd, Piotr Kuna, Marek Sanak, Lucyna Mastalerz // Clinical & Experimental Allergy ; ISSN 0954-7894. — 2021 — vol. 51 iss. 8, s. 1046–1056. — Bibliogr. s. 1054–1056, Abstr. — Publikacja dostępna online od: 2021-04-27